Video Series: Current Topics in the Treatment of Advanced PCa
Philip Kantoff, MD, Andrew Armstrong, MD, William Oh, MD, and A. Oliver Sartor, MD, discuss advances in treatment of castration-resistant prostate cancer and metastatic castration-resistant prostate cancer, specifically newer hormonal therapies.
Latest Prostate Cancer News
Does not improve overall survival in metastatic castration-resistant prostate cancer.
Shows the strongest correlation between biochemical recurrence and subsequent systemic progression.
The odds of developing lethal prostate cancer were increased by 6.9 to 12.6 times for men aged 40 to 59 years with higher PSA values.
More effective tools are needed to support the long-term recovery of patients who survive cancer.
Three in 4 young or middle-aged patients receive aggressive therapies in the last months of life.
In prostate cancer, adjuvant docetaxel without hormone therapy did not improve biochemical disease-free survival after radical prostatectomy.
Transrectal ultrasound-guided (TRUS) prostate biopsy poorly detects and rules out clinically significant prostate cancer.
Adding enzalutamide to abiraterone acetate and leuprolide acetate does not appear to be effective for the treatment of localized high-risk prostate cancer.
A predictive model for chemotherapy toxicity found that 58% of patients experienced grade 3 toxicity or higher.
TURP and EBRT after seed implantation are associated with development of urge urinary incontinence.
Adding short-term androgen suppression to salvage radiotherapy may benefit men with prostate cancer who have undergone radical prostatectomy.
Most patients have unrealistic survival expectations, which may compromise their ability to make informed treatment decisions.
Patients with a relatively low tumor risk and good general health status appear to experience the best survival.
In a meta-analysis, men with benign prostatic hyperplasia had a 2.9 times and 1.7 times increased incidence of prostate cancer and bladder cancer, respectively.
High rates of screening for individuals with limited long-term life expectancy for all tools.
Prostate Cancer Videos
Sign up for free e-Newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
- Blacks With Diabetes and CKD Have Higher CVD Risk
- Worse Re-transplant Outcomes for HIV Positive Patients
- Race, Procedure Type Influence Morbidity in Pediatric Surgery Patients
- Parathyroidectomy Rates Stable Despite Changes in Medical Therapy
- Early Recurrence After Laparoscopic Radical Cystectomy Explored